Calithera Biosciences Inc
NASDAQ:CALA
Income Statement
Earnings Waterfall
Calithera Biosciences Inc
Revenue
|
0
USD
|
Operating Expenses
|
-42.1m
USD
|
Operating Income
|
-42.1m
USD
|
Other Expenses
|
20.8m
USD
|
Net Income
|
-21.3m
USD
|
Income Statement
Calithera Biosciences Inc
Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
4
N/A
|
11
+173%
|
19
+63%
|
26
+39%
|
27
+4%
|
37
+36%
|
30
-20%
|
22
-25%
|
17
-23%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
3
N/A
|
10
+225%
|
10
N/A
|
10
N/A
|
7
-31%
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||
Operating Expenses |
(17)
|
(19)
|
(22)
|
(25)
|
(28)
|
(32)
|
(33)
|
(35)
|
(37)
|
(37)
|
(38)
|
(39)
|
(41)
|
(46)
|
(56)
|
(65)
|
(73)
|
(78)
|
(80)
|
(85)
|
(89)
|
(91)
|
(93)
|
(94)
|
(89)
|
(91)
|
(91)
|
(86)
|
(83)
|
(78)
|
(124)
|
(118)
|
(112)
|
(104)
|
(42)
|
|
Selling, General & Administrative |
(4)
|
(4)
|
(5)
|
(7)
|
(8)
|
(9)
|
(9)
|
(9)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
(12)
|
(13)
|
(13)
|
(13)
|
(13)
|
(13)
|
(14)
|
(14)
|
(15)
|
(17)
|
(17)
|
(19)
|
(19)
|
(20)
|
(21)
|
(20)
|
(22)
|
(21)
|
(20)
|
(19)
|
(16)
|
(14)
|
|
Research & Development |
(13)
|
(14)
|
(16)
|
(19)
|
(20)
|
(23)
|
(24)
|
(25)
|
(27)
|
(27)
|
(28)
|
(27)
|
(30)
|
(34)
|
(43)
|
(52)
|
(59)
|
(65)
|
(66)
|
(71)
|
(75)
|
(75)
|
(76)
|
(76)
|
(71)
|
(72)
|
(71)
|
(65)
|
(62)
|
(56)
|
(103)
|
(99)
|
(94)
|
(88)
|
(29)
|
|
Operating Income |
(17)
N/A
|
(19)
-11%
|
(22)
-14%
|
(25)
-17%
|
(28)
-9%
|
(32)
-13%
|
(33)
-4%
|
(35)
-5%
|
(37)
-7%
|
(37)
+1%
|
(38)
-4%
|
(34)
+10%
|
(30)
+14%
|
(28)
+7%
|
(30)
-7%
|
(38)
-27%
|
(36)
+5%
|
(49)
-36%
|
(57)
-18%
|
(68)
-18%
|
(89)
-31%
|
(91)
-2%
|
(93)
-2%
|
(94)
-1%
|
(89)
+4%
|
(91)
-2%
|
(91)
0%
|
(86)
+6%
|
(80)
+8%
|
(68)
+15%
|
(114)
-69%
|
(109)
+5%
|
(106)
+3%
|
(104)
+2%
|
(42)
+60%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
2
|
1
|
1
|
1
|
0
|
0
|
(0)
|
3
|
2
|
3
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
Pre-Tax Income |
(17)
N/A
|
(19)
-11%
|
(22)
-14%
|
(25)
-17%
|
(28)
-9%
|
(31)
-13%
|
(33)
-4%
|
(34)
-5%
|
(37)
-7%
|
(37)
+1%
|
(38)
-4%
|
(34)
+11%
|
(29)
+15%
|
(26)
+9%
|
(28)
-6%
|
(35)
-27%
|
(33)
+6%
|
(46)
-38%
|
(55)
-18%
|
(65)
-19%
|
(86)
-32%
|
(88)
-2%
|
(90)
-3%
|
(91)
-1%
|
(87)
+4%
|
(89)
-3%
|
(90)
-1%
|
(86)
+4%
|
(80)
+7%
|
(68)
+14%
|
(115)
-68%
|
(109)
+6%
|
(103)
+5%
|
(102)
+1%
|
(40)
+61%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(17)
|
(19)
|
(22)
|
(25)
|
(28)
|
(31)
|
(33)
|
(34)
|
(37)
|
(37)
|
(38)
|
(34)
|
(29)
|
(26)
|
(28)
|
(35)
|
(33)
|
(46)
|
(55)
|
(65)
|
(86)
|
(88)
|
(90)
|
(91)
|
(87)
|
(89)
|
(90)
|
(86)
|
(80)
|
(68)
|
(115)
|
(109)
|
(103)
|
(102)
|
(40)
|
|
Net Income (Common) |
(17)
N/A
|
(19)
-11%
|
(22)
-14%
|
(25)
-17%
|
(28)
-9%
|
(31)
-13%
|
(33)
-4%
|
(34)
-5%
|
(37)
-7%
|
(37)
+1%
|
(38)
-4%
|
(34)
+11%
|
(29)
+15%
|
(26)
+9%
|
(28)
-6%
|
(35)
-27%
|
(33)
+6%
|
(46)
-38%
|
(55)
-18%
|
(65)
-19%
|
(86)
-32%
|
(88)
-2%
|
(90)
-3%
|
(91)
-1%
|
(87)
+4%
|
(89)
-3%
|
(90)
-1%
|
(86)
+4%
|
(80)
+7%
|
(68)
+14%
|
(115)
-68%
|
(107)
+7%
|
(85)
+21%
|
(84)
+2%
|
(21)
+75%
|
|
EPS (Diluted) |
-21.58
N/A
|
-24.01
-11%
|
-94.39
-293%
|
-28.24
+70%
|
-30.83
-9%
|
-34.51
-12%
|
-36.26
-5%
|
-37.35
-3%
|
-38.85
-4%
|
-37.29
+4%
|
-39.17
-5%
|
-26.99
+31%
|
-16.29
+40%
|
-14.89
+9%
|
-16.86
-13%
|
-19.79
-17%
|
-18.62
+6%
|
-25.33
-36%
|
-29.85
-18%
|
-33.56
-12%
|
-41.63
-24%
|
-32.57
+22%
|
-37.91
-16%
|
-28.05
+26%
|
-24.95
+11%
|
-25.29
-1%
|
-26.2
-4%
|
-23.84
+9%
|
-21.62
+9%
|
-18.45
+15%
|
-31.18
-69%
|
-23.14
+26%
|
-14.89
+36%
|
-17.15
-15%
|
-4.6
+73%
|